Preterm Labor Treatment Market by Drugs, Dosage Form, End User and Geography. Key Players are Pfizer, Novartis, Merck, Sanofi, Johnson & Johnson, GlaxoSmithKline, AstraZeneca and Cipla.

Precision Business Insights (PBI) in its report titled “Preterm Labor Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the preterm labor treatment market revenue growth over forecast period.

The preterm labor treatment market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2025. Increase in premature birth cases and rapid increase birth-rate will create a demand for the preterm labor treatment market. Increase in technological advancements, increasing demand for preterm therapeutics and diagnostics, increase in R & D investments by market players, increase in support from government are expected to propel the growth of preterm labor treatment market.

Preterm labor treatment market segmented on the basis of drug, dosage form, treatment type and end user.

Pharmaceutical Treatment Segment Expected to Dominate the Market

Based on treatment method, the market was segmented into devices and pharmaceutical treatment. In 2017, the pharmaceutical treatment segment held the major market share among the treatment type segment. This is primarily attributed to its ease of use and its increasing recommendation for its use by the healthcare providers as well as its ease of use, and lesser side effects. The pharmaceutical treatment segment is also expected to grow at the fastest rate during the coming years.

Hospitals and Pharmacy Will Dominate the Revenue Share.

Based on end-user type, preterm labor treatment market segmented into hospitals, nursing homes pharmacy and others. The hospitals and clinics are witnessed to account for major revenue share over the forecast period due to advancement in the technology and increased research programs.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/preterm-labor-treatment-market/

North America, Accounts for Major Revenue Share for Preterm Labor Treatment Market

Precision Business Insights (PBI), preterm labor treatment market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for major revenue share owing to presence of large number of market players. North America is the largest market followed by Europe in Preterm labor treatment market owing to presence of large number of market players, favourable government initiatives and regulatory framework, high incidence of preterm births. For instance, in 2007 a campaign was held in U.S. in the name of ‘Healthy People 2010’ which led to reduction of XX% to XX% preterm birth rate. Asia Pacific is anticipated to show significant growth in this market owing to increase in awareness and disposable income of developing economies, growing population pool, increased healthcare infrastructure.

U.S FDA Approval Play Vital Role in Preterm Labor Treatment Market

Approval from U.S FDA and launch of the product will play an important role in the development of the market. For instance, in April 2016, AMAG Pharmaceuticals introduced FDA approved single dose, preservative free Makena to reduce risk of preterm birth.

Download free Sample Report at https://bit.ly/2RMZedi

Key players in the market include Pfizer (U.S.), Novartis (Switzerland), Merck & Co (U.S.), Sanofi (France), Johnson & Johnson (U.S.), GlaxoSmithKline (UK), AstraZeneca (UK), Cipla (India).

Detailed Segmentation

By Drug

o Tocolytic Drugs
o Beta – Mimetic
o Calcium Channel Blockers
o NSAIDS
o Corticosteroids
o Magnesium Sulphate
o Antibiotics
o Others

By Dosage Form

o Tablets
o Capsules
o Injection

By Treatment

o Devices
o Pharmaceuticals

By End Users

o Hospitals
o Pediatric and Neonatal Clinics
o Nursing Homes
o Pharmacy

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Gulf Corporation Council Countries(GCCC)
 Rest of MEA

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.